1Globe Biomedical of Hong Kong today announced details of their upcoming Health Conference which will be held on Hong Kong on Thursday 29th October 2020.
Online PR News – 02-October-2020 – CENTRAL DISTRICT – 1Globe Biomedical’s conference will start at 6:00pm local time and will be attended by over 100 healthcare start-up companies from the Asia-Pacific region and guests from pharmaceutical companies where they will address business development and corporate ventures.
1Globe Biomedical’s Chief Executive Officer commented on the upcoming health conference saying “This year has been extremely tough in terms of the COVID-19 pandemic. The economic impact of Covid-19 on the healthcare has taken its toll and hospitals haven’t been able to cope with the thousands of cases around the world. This conference can unite the region and put together an ecosystem that will illustrate the positive measures that continue to take place within the heath and biomedical industry.”
1Globe Biomedical’s Chief Executive Officer also added “In times like these, now more than ever, it is essential to strengthen the global support needed for innovation in health which is the reason 1Globe Biomedical is hosting this event. The objective of 1Globe Biomedical is to advance and accelerate the development of healthcare solutions for patients in need and with valuable information in biomedical science, we will be able to move forward in a bid to eradicate future pandemics.”
About Us - 1Globe Biomedical
1Globe Biomedical is a clinical stage biotechnology company pioneering the development of receptor T (1BioCARs™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” receptor T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.